COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01453452
Recruitment Status : Completed
First Posted : October 17, 2011
Last Update Posted : January 18, 2020
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group

Brief Summary:

RATIONALE: Physical activity, diet, and counseling may help breast and colorectal cancer survivors to lose weight and improve their quality of life.

PURPOSE: This phase II trial studies how well exercise, diet, and counseling work in improving physical activity and weight loss in overweight women who are breast and colorectal cancer survivors.

Condition or disease Intervention/treatment Phase
Anxiety Disorder Breast Cancer Cognitive/Functional Effects Colorectal Cancer Depression Fatigue Pain Psychosocial Effects of Cancer and Its Treatment Weight Changes Behavioral: behavioral dietary intervention Behavioral: exercise intervention Other: counseling intervention Procedure: quality-of-life assessment Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 50 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Study Start Date : March 2012
Actual Primary Completion Date : August 2015
Actual Study Completion Date : January 2017

Arm Intervention/treatment
Experimental: Exercise and Lifestyle counseling
Patients will receive behavioral dietary intervention & counseling intervention by phone, exercise intervention at Curves(R) facility, and take a quality-of-life assessment online.
Behavioral: behavioral dietary intervention
Reduce caloric intake by 500 kcal/day, increase fruit and vegetable intake to 5 or more servings per day, and limit daily calories from fat to be < 30%. Diet will be measured using 3 repeated 24-hr diet recalls. Participants will receive information on the recommended dietary modifications via mailed materials and telephone counseling sessions.

Behavioral: exercise intervention
150 min/wk of moderate exercise through use of the Curves® centers, engage in physical activity outside of Curves®, and use pedometers to track activity.

Other: counseling intervention
14 40-min behavioral counseling sessions via telephone with the goal of increasing intervention adherence and increasing participant retention.

Procedure: quality-of-life assessment
PROMIS-43 - online questionnaire to assess quality of life.

Primary Outcome Measures :
  1. Attendance of ≥ 2 Curves sessions/week for a minimum of 36 of the 52 weeks of intervention [ Time Frame: 1 year from registration ]
  2. Increase in fruit and vegetable consumption by 1 full serving per day (not including iceberg lettuce, potatoes, or fruit juices) OR reduce caloric intake by 100 kcal/day [ Time Frame: 1 year from registration ]

Secondary Outcome Measures :
  1. Changes in anthropometric measures (weight, BMI, waist circumference, hip circumference) [ Time Frame: 1 year from registration ]
  2. Changes in body composition (% body fat as assessed by DXA scan at 12 months only) [ Time Frame: 1 year from registration ]
  3. Changes in minutes spent per week in moderate-to-vigorous intensity aerobic activity using Curves attendance records and a 7-day physical activity recall assessment [ Time Frame: 1 year from registration ]
  4. Changes in dietary intake patterns based on three separate 24-hour diet recalls [ Time Frame: 1 year from registration ]
  5. Changes in metabolic and hormonal biomarkers associated with breast and colorectal cancer-recurrence risk (fasting insulin, fasting glucose, hemoglobin A1C, bioavailable estradiol, free testosterone, and adiponectin) [ Time Frame: 3 years ]
  6. Changes in anxiety, depression, fatigue, sleep, satisfaction with social roles, pain, and physical function as measured by the PROMIS-43 [ Time Frame: 1 year from registration ]
  7. DNA methylation patterns [ Time Frame: 3 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   up to 120 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No


  • Participants must be women with a previous diagnosis of stage I, II, or III invasive breast cancer or colorectal cancer

    • Participants must have no evidence of disease at the time of registration and no history of metastases (M0)
  • Participants must have a body mass index ≥ 25 kg/m^2 measured within 28 days of registration
  • Participants must be considered sedentary (defined as < 60 minutes of moderate to vigorous physical activity per week; moderate exercise defined as exercising to the point of sweating)
  • Participants must be willing to submit blood samples for biomarkers (insulin, glucose, HgbA1C, estradiol, and testosterone) and undergo DXA scans, and must be given the option to consent for specimen submission for banking and future translational medicine studies
  • Participants must be willing and able to attend a Curves fitness center at least 3 times per week for 12 months


  • Participants must be post-menopausal, as defined by at least one of the following:

    • At least 12 months since the last menstrual period
    • Prior bilateral oophorectomy
    • Previous hysterectomy with one or both ovaries left in place (or previous hysterectomy in which documentation of bilateral oophorectomy is unavailable) AND follicle-stimulating hormone (FSH) values consistent with the institutional normal values for the post-menopausal state

      • If participant is under the age of 55, FSH levels must be obtained within 28 days prior to registration
  • Zubrod performance status of 0
  • Participants must have no abnormal changes on a regular (non-nuclear) cardiovascular exercise stress test (using a treadmill or bicycle) as measured by electrocardiogram (EKG)

    • EKG must be within institutional limits of normal
    • Results of previous cardiac exercise stress test may be used as long as it was done within 3 months prior to registration
  • Participants must not have evidence of uncontrolled hypertension
  • Participants with diabetes, pre-diabetes, and/or metabolic syndrome must have HgbA1C ≤ 8% within the past 28 days

    • Current use of diabetes medications is allowed
  • No other prior malignancy is allowed except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or other cancer for which the participant has been disease-free for > 5 years
  • Participants must not be active smokers within past 90 days; active smoking is defined as any smoking, even a puff
  • Participants must have regular access to the internet in order to receive monthly nutrition-program newsletter e-mails and to complete study questionnaires online
  • Participants must be able to understand, speak, and read English
  • Participants must have a home phone or cell phone and agree to participate in the 14 (40-minute) behavioral counseling sessions and 9 (20-30-minute) telephone interviews
  • Participants must have a baseline physical exam and physician clearance (primary care provider, medical oncologist, or surgical oncologist) to participate in the weight loss and exercise prior to enrollment within 60 days of registration; copy of physician clearance document must be submitted


  • Participants must be 90 days to 730 days post-surgery, chemotherapy, and radiation therapy

    • Current hormonal therapy is allowed among breast cancer participants
    • Other concurrent anti-cancer therapies, including Herceptin, are not allowed
    • Surgery is defined as any major surgical procedure (resection or reconstructive) that would preclude inclusion in the exercise program

      • If the participant has had a remedial surgical procedure (e.g., revision of reconstruction) or persistent complications from her original operation, approval will be obtained from the participant's surgeon prior to enrollment

        • Persistent complications may include, but are not limited to, prolonged wound healing, hernias, or ostomy prolapse

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01453452

Show Show 58 study locations
Sponsors and Collaborators
Southwest Oncology Group
National Cancer Institute (NCI)
Layout table for investigator information
Study Chair: Heather Greenlee, PhD, ND Herbert Irving Comprehensive Cancer Center
Study Chair: Dawn Hershman, MD Herbert Irving Comprehensive Cancer Center
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Southwest Oncology Group Identifier: NCT01453452    
Other Study ID Numbers: S1008
S1008 ( Other Identifier: SWOG )
U10CA037429 ( U.S. NIH Grant/Contract )
NCI-2011-03539 ( Other Identifier: CTRP )
First Posted: October 17, 2011    Key Record Dates
Last Update Posted: January 18, 2020
Last Verified: January 2020
Keywords provided by Southwest Oncology Group:
psychosocial effects of cancer and its treatment
cancer survivor
stage IA breast cancer
stage IB breast cancer
stage II breast cancer
stage IIIA breast cancer
stage IIIB breast cancer
stage IIIC breast cancer
stage I colon cancer
stage IIA colon cancer
stage IIB colon cancer
stage IIC colon cancer
stage IIIA colon cancer
stage IIIB colon cancer
stage IIIC colon cancer
stage I rectal cancer
stage IIA rectal cancer
stage IIB rectal cancer
stage IIC rectal cancer
stage IIIA rectal cancer
stage IIIB rectal cancer
stage IIIC rectal cancer
weight changes
anxiety disorder
cognitive/functional effects
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Colorectal Neoplasms
Neoplasms by Site
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Colonic Diseases
Body Weight
Weight Loss
Body Weight Changes
Anxiety Disorders
Breast Diseases
Skin Diseases
Behavioral Symptoms
Mental Disorders
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases